Rheumatoid Arthritis: The Weekly Methotrexate Rule, What Treat to Target Means and How to Stay Safe on It
Rheumatoid arthritis is not a pain problem that happens to involve joints. It is an immune system attacking the lining of joints, and the pain is the least of it — the damage accumulates whether or not a particular week hurts.
Which produces the single most important distinction in managing it: there are drugs that make you feel better, and there are drugs that change what happens to your joints. They are not the same drugs, and feeling well on the first kind while not taking the second is the commonest way this disease causes permanent harm.
⚠️ Before anything else on this page, the rule that has killed people when it was not followed.
Methotrexate for rheumatoid arthritis is taken ONCE A WEEK. Never daily.
Tablets are usually 2.5 mg, so a 15 mg dose means taking six tablets together, on one day, once a week. That looks wrong to anyone used to daily medicine, and it is correct.
Taken daily, methotrexate shuts down the bone marrow. It causes mouth ulceration, collapse of blood counts, overwhelming infection and death. This is one of the best-documented fatal medication errors in medicine, and it happens through exactly that misunderstanding.
Pick one day of the week, write it on the box, and never deviate. If you are ever unsure whether you took it, ask before taking more.
🎯 What treat to target actually means
The phrase appears everywhere and is rarely explained, which makes it sound like a slogan rather than a schedule. It is a schedule.
| What happens | |
|---|---|
| The target | Remission, or low disease activity where remission is not achievable. Measured with a composite score combining tender joints, swollen joints, an inflammation blood test and your own rating — not by how you felt at the appointment |
| How often it is checked | Every one to three months while active, then every three to six months once stable |
| The three-month rule | If there has been no meaningful improvement by three months, the treatment changes |
| The six-month rule | If the target is not reached by six months, the treatment changes again |
The whole point is that the plan moves on a timetable rather than drifting. Years spent on a drug that half worked is how joints are lost, and it happens because appointments get rescheduled and everyone adapts to the current state.
What to ask at your next appointment: what is my score, what is the target, and what happens if I am not there by the next visit. Those three questions move the care forward more than any symptom description.
🖤 Why pain is a poor guide
Two mismatches catch people out, and both are worth holding in mind.
Low pain does not mean low inflammation. Anti-inflammatory tablets, and steroids especially, reduce pain while the immune process continues. Joint erosion can progress through a comfortable period.
High pain does not always mean active disease. Once joints have been damaged, there is mechanical pain on top of the inflammatory kind, and it does not respond to immune treatment because it is not immune in origin.
Which is why disease activity is measured with joint counts and blood tests rather than by how bad the week was. Inflammatory markers can also be normal in genuinely active disease, so no single number decides anything.
The findings that mean inflammation rather than wear: morning stiffness over an hour, swelling that is soft and warm rather than bony, symmetry, involvement of knuckles and the middle joints of the fingers and the balls of the feet, better with movement and worse after rest, and the systemic layer — fatigue that is out of proportion, low-grade unwellness, poor appetite.
💊 The drug that changes the disease
Methotrexate has been the anchor of rheumatoid arthritis treatment for decades, and it remains the first drug in essentially every guideline. It is not a painkiller. At the low weekly doses used here it modulates immune activity and slows or stops joint erosion.
Worth saying plainly because the name frightens people: the doses used in cancer treatment are many times higher and given completely differently. In rheumatoid arthritis this is a low-dose, weekly, long-term, well-characterised treatment that many people take for years with routine monitoring and no drama.
| How it is used | |
|---|---|
| Starting dose | 7.5 to 15 mg once weekly |
| Target dose | Increased over four to eight weeks to 20 to 25 mg once weekly, as tolerated |
| Tablet strength | Usually 2.5 mg, so the weekly dose is several tablets taken together |
| Folic acid | 5 mg once weekly, on a different day — usually 24 to 48 hours after. Non-negotiable |
| Time to work | Some effect at four to six weeks, full effect at three months. Not quick |
| If tablets cause nausea | A weekly injection often solves it and absorbs better |
The folic acid line deserves emphasis because it gets skipped. Methotrexate works partly by interfering with folate, and that is where most of the unpleasant side effects come from — nausea, mouth ulcers, raised liver enzymes. Taking folic acid on a separate day removes much of that without reducing the benefit, and it is the main reason people are able to stay on treatment.
🩸 The blood tests, and why they are not optional
Methotrexate requires monitoring. This is the trade for a drug that genuinely protects joints, and it is a small trade.
- 📊 Full blood count, liver function and kidney function
- 📅 Every two to four weeks while the dose is being increased, then every eight to twelve weeks once stable
- 🔎 What they are looking for: falling white cells or platelets, rising liver enzymes, declining kidney function. All are usually caught early and managed by adjusting the dose
Anyone taking this without monitoring is taking a different and considerably worse risk than anyone taking it with monitoring. If blood tests are difficult to arrange, that is a problem to solve rather than a step to skip.
🚫 The interaction that causes hospital admissions
⚠️ Do not take trimethoprim or co-trimoxazole while on methotrexate.
Both are folate antagonists, like methotrexate itself, and the combination causes severe bone marrow suppression. This happens in real life because trimethoprim is a standard antibiotic for urinary infections, and the connection is not made at the pharmacy counter.
Tell any prescriber you are on methotrexate before accepting an antibiotic, and if you are handed trimethoprim or co-trimoxazole, query it. There are alternatives for every indication.
Other combinations to raise rather than assume: high-dose or long-term anti-inflammatories with impaired kidney function, since both are cleared renally; proton pump inhibitors at high dose; and alcohol, where the sensible position is low intake rather than the total abstinence once advised — heavy drinking alongside methotrexate is a genuine liver risk.
📞 Symptoms that mean stop and ring today
These are uncommon, and recognising them is why they rarely become serious.
- 🌡️ Fever, sore throat, or mouth ulcers that appear suddenly — possible marrow suppression, needs an urgent blood count
- 🫁 A new dry cough or breathlessness — methotrexate can rarely inflame the lungs, and this needs assessing rather than waiting out
- 🟡 Yellowing of eyes or skin, dark urine, or persistent nausea and right upper abdominal pain — liver
- 🩸 Unexplained bruising or bleeding
- 💧 Vomiting or diarrhoea severe enough to dehydrate you — reduced kidney clearance raises methotrexate levels, so hold the dose and seek advice
- 🌡️ Any significant infection — the weekly dose is usually held until it has resolved. Not for an ordinary cold, and yes for anything needing antibiotics
👶 Pregnancy, and the two-year drug
⚠️ This matters more here than in most diseases, because rheumatoid arthritis affects women about three times as often as men and frequently begins in the childbearing years.
Methotrexate must not be taken in pregnancy. It causes birth defects and pregnancy loss. Current guidance is to stop it, with planning, around three months before trying to conceive — and that advice applies to men as well as women. Reliable contraception is needed while taking it.
Leflunomide is the bigger trap. It lingers in the body for up to two years after the last tablet, so simply stopping it is not enough. A specific washout procedure with a binding medicine and blood level checks is required before pregnancy is safe.
None of this means rheumatoid arthritis prevents pregnancy. It means the plan is changed in advance, with a rheumatologist, to drugs that are compatible — several are. Raise it early rather than at the point of deciding.
🛡️ Living on immune-modifying treatment
These drugs reduce immune activity to a degree. The risk is real and manageable, and the management is mostly vaccination and a lower threshold for getting things looked at.
- 💉 Inactivated vaccines are encouraged — annual influenza, pneumococcal, and COVID vaccination as advised. These are more important on this treatment, not less
- 🚫 Live vaccines are contraindicated — including measles, mumps and rubella, yellow fever, and the live shingles vaccine. Plan travel vaccination well ahead and mention your medication every time
- 🧪 Before starting a biologic or a JAK inhibitor, screening for tuberculosis and hepatitis B and C is standard, because these treatments can reactivate dormant infection
- 🌡️ Get infections seen earlier than you otherwise would. Fever, a productive cough, burning on passing urine, or spreading skin redness all warrant contact rather than waiting
- 🏥 Carry a card or note saying which immune-modifying drug you take. It changes decisions in an emergency department
- 💇 Shingles risk is raised with JAK inhibitors, and vaccination with the non-live version is worth asking about
🔄 When methotrexate is not enough
It is enough for a substantial proportion of people, and for the rest the sequence is well established. Briefly, since the escalation is covered in detail in our guide to moderate to severe rheumatoid arthritis.
| Step | Options |
|---|---|
| Optimise first | Is the dose at target? Has it had three months? Would the injection work better than tablets? |
| Add or switch conventional | Leflunomide, sulfasalazine, or hydroxychloroquine — alone or combined, often with methotrexate retained |
| Targeted therapy | A biologic, or a JAK inhibitor such as baricitinib, usually added to methotrexate rather than replacing it |
Steroids have a specific place in this: a short course or an injection to settle a flare or to bridge the weeks while a new drug takes effect. Lowest dose, shortest time, and with bone protection if the course runs on. They are an excellent bridge and a poor destination.
And the symptom layer sits alongside all of it. Mobic (Meloxicam) at 7.5 to 15 mg once daily, or etoricoxib, reduce inflammatory pain and stiffness enough to keep moving — which matters, because movement is part of the treatment. Never two anti-inflammatories together, always with food, and a stomach-protecting tablet where there is any ulcer history or age over 65. What these do and do not reach is set out in our guide to joint pain and which treatment reaches which joint.
❤️ The complication that is not a joint
This is systematically under-addressed and it is the leading cause of death in this disease.
Rheumatoid arthritis roughly doubles cardiovascular risk, independently of the usual factors. Chronic inflammation accelerates arterial disease, which is why the heart risk of someone with poorly controlled rheumatoid arthritis resembles that of someone with diabetes.
Two things follow. Controlling the inflammation itself reduces that risk — which is another argument for treating to target rather than to comfort. And the ordinary cardiovascular work still has to be done: blood pressure, cholesterol, and above all smoking. See our guides to blood pressure and cholesterol.
The other things outside the joints, worth knowing so they are reported rather than endured:
- 🫁 Lungs — a persistent dry cough or breathlessness needs assessing, since the disease itself can affect lung tissue
- 👁️ Eyes — dryness is common; a painful red eye is urgent
- 🩸 Anaemia of chronic inflammation, which contributes to the fatigue
- 🦴 Bone thinning, from the disease, reduced activity and any steroid use
- 😢 Dry eyes and mouth together, which can mean an overlapping condition
- 🧠 Neck pain with arm symptoms in long-standing disease — worth mentioning before any operation, because it affects how the airway is managed
🚬 The one change that outperforms everything else you control
Smoking causes rheumatoid arthritis, makes it worse, and reduces how well the medication works. The association is among the strongest between any lifestyle factor and any autoimmune disease, and it is particularly tied to the antibody-positive form.
Stopping improves treatment response and lowers the cardiovascular risk above at the same time. It is the single highest-value thing in a patient hands here, and the methods that actually work are in our guide to smoking cessation.
The rest, in order of how much the evidence supports them:
- 🏃 Exercise. It does not damage inflamed joints — the old advice to rest them was wrong. Regular activity improves pain, function, fatigue and cardiovascular risk. Reduce load during a flare, keep gentle movement
- 🦷 Dental health. Gum disease is associated with rheumatoid arthritis and with worse control, probably through the same immune mechanisms. Unglamorous and worth acting on
- ⚖️ Weight. Excess weight reduces the chance of reaching remission and loads the joints twice over
- 🐟 Diet. A Mediterranean pattern and oily fish have modest supportive evidence. No diet treats this disease, and anyone selling one is selling something else
- 😴 Sleep. Poor sleep amplifies pain and fatigue measurably, and the two feed each other
📈 What good control looks like
Not the absence of all symptoms, and more than the absence of pain.
- 🌅 Morning stiffness down to minutes rather than an hour or more — often the earliest sign treatment is working
- ✋ No soft, warm swelling in the joints on examination
- 📊 Inflammatory markers settled, and a composite score at the agreed target
- 🔋 Fatigue lifting, which people often notice before anything to do with the joints
- 🚪 Function restored —> grip, stairs, jars, buttons, a full working day
- 📉 Flares shorter and further apart, and recovering in days rather than weeks
Treatment is usually continued once control is reached, because stopping commonly leads to relapse. Reducing doses in sustained remission is sometimes possible and is a decision to make deliberately with a rheumatologist, not by quietly tapering off when things feel fine.
📞 When to seek help
🚨 Urgently: fever with sudden mouth ulcers or sore throat on methotrexate; new breathlessness or a dry cough; a painful red eye; a single hot swollen joint with fever, which may be infection rather than a flare; chest pain or breathlessness; or jaundice.
Same week:
- If you may have taken methotrexate on the wrong schedule — ring immediately rather than waiting to see how you feel
- If you have been handed trimethoprim or co-trimoxazole while on methotrexate
- Any significant infection, to ask whether to hold the weekly dose
- Blood tests overdue, which is a reason to chase rather than to coast
- New or worsening joint swelling, or a flare lasting beyond a couple of weeks
- Planning a pregnancy, or an unplanned pregnancy — same week, both for methotrexate and especially for leflunomide
- Planning travel vaccination or any surgery
- No improvement after three months at a proper dose — that is the point at which the plan should change by design
- Nausea or mouth ulcers making you want to stop — these are usually fixable with folic acid timing, an antiemetic, or switching to injection, and stopping is the worst of the available options
- Persistent dryness of eyes and mouth, or fatigue that is not improving with otherwise good control
❓ Frequently asked questions
How often is methotrexate taken for rheumatoid arthritis?
Once a week, never daily. Tablets are usually 2.5 mg, so a weekly dose means several taken together on one chosen day. Daily dosing causes fatal bone marrow suppression and is a well-documented medication error.
Why do I need folic acid with methotrexate?
Because methotrexate interferes with folate, which causes most of the nausea, mouth ulcers and liver enzyme rises. Folic acid 5 mg weekly, on a different day, removes much of that without reducing the benefit.
What is the methotrexate dose for rheumatoid arthritis?
Usually 7.5 to 15 mg once weekly to start, increased over four to eight weeks to 20 to 25 mg weekly as tolerated. Some effect appears at four to six weeks, with full effect around three months.
Which antibiotic must I avoid on methotrexate?
Trimethoprim and co-trimoxazole. Both are folate antagonists and the combination causes severe bone marrow suppression. Tell any prescriber you take methotrexate before accepting an antibiotic.
Can an NSAID control rheumatoid arthritis?
No. Anti-inflammatories reduce pain and stiffness but do nothing to prevent joint erosion, which continues through comfortable periods. They support function alongside a disease-modifying drug, never instead of one.
What does treat to target mean in practice?
Aiming for remission or low disease activity, measured by a composite score, reassessed every one to three months. If there is no meaningful improvement by three months or the target is unmet at six, the treatment changes.
How long before methotrexate works?
Some effect at four to six weeks and full effect around three months. It is not a painkiller and nothing happens in the first fortnight, which is why three months is the point at which the plan is reassessed.
Can I get pregnant while taking these drugs?
Methotrexate must be stopped around three months before conceiving, for men as well as women. Leflunomide persists up to two years and needs a specific washout with blood level checks. Raise it well in advance.
Which vaccines can I have on immune-modifying treatment?
Inactivated vaccines are encouraged, including annual influenza and pneumococcal. Live vaccines such as measles, mumps and rubella, yellow fever and live shingles are contraindicated. Mention your medication every time.
Does smoking affect rheumatoid arthritis?
Substantially. Smoking helps cause the disease, worsens it, and reduces how well medication works. Stopping improves treatment response and lowers the raised cardiovascular risk that comes with the condition.
📑 Sources and editorial
- Rheumatology society recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying drugs, including first-line methotrexate and escalation sequences
- Treat-to-target recommendations in rheumatoid arthritis, including remission and low disease activity definitions, composite activity measures, and the three-month and six-month reassessment intervals
- Guidance on low-dose weekly methotrexate in inflammatory arthritis, including starting and target doses, titration, subcutaneous administration and folate supplementation
- Patient safety alerts and published case series on inadvertent daily methotrexate administration and resulting fatal myelosuppression
- Prescribing information for methotrexate, including monitoring schedules for full blood count, hepatic and renal function, pulmonary toxicity, and contraindications
- Literature on the interaction between methotrexate and trimethoprim or co-trimoxazole and resulting pancytopenia
- Reproductive health guidance in rheumatic disease, including preconception withdrawal intervals for methotrexate in both sexes and the leflunomide elimination procedure
- Vaccination guidance for patients on immunosuppressive and immunomodulatory therapy, including live vaccine contraindications and screening for tuberculosis and viral hepatitis before biologic or targeted synthetic therapy
- Evidence on cardiovascular risk in rheumatoid arthritis, the contribution of disease activity, and the effect of inflammation control on that risk
- Reviews of extra-articular manifestations of rheumatoid arthritis, including interstitial lung disease, ocular involvement, anaemia of inflammation, osteoporosis and cervical spine disease
- Studies of smoking as a causal and prognostic factor in rheumatoid arthritis, including its relationship to antibody-positive disease and to treatment response
- Evidence on exercise safety and benefit in inflammatory arthritis, and on periodontal disease, body weight and dietary pattern as modifying factors
- Guidance on glucocorticoid bridging therapy, dose minimisation and bone protection
- Related reading: moderate to severe rheumatoid arthritis, joint pain and which treatment reaches which joint, smoking cessation aids, blood pressure, cholesterol
- Related products: Methotrexate, Arava (Leflunomide), Azulfidine (Sulfasalazine), Olumiant (Baricitinib), Mobic (Meloxicam), arthritis category
- RXshop Editorial Team — reviewed by Emily Chen, MD, MPH — Internal Medicine Specialist
Medical Disclaimer: The information in this article is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek guidance from a qualified healthcare provider with any questions you may have regarding a medical condition, and before starting, stopping or changing any medication.